POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (9.20.2021, 9:50am CEST, WHO):   U.S. 156,736    India 34,403    Brazil 14,780    United Kingdom 26,326    Russia 19,905    Turkey 28,118    France 7,690    Iran 18,021    Argentina 2,510    Columbia 1,570    Spain 1,682    Italy 5,115    Indonesia 3,835    Germany 11,022    Mexico 13,217    South Africa 4,214    Ukraine 6,624    Philippines 21,261    Peru 1,018    Malaysia 18,815    Netherlands 2,130    Iraq 3,923    Japan 6,020    Canada 4,289    Bangladesh 1,907    Thailand 14,555    Pakistan 3,012    Israel 3,171    Sweden 1,200    Romania 4,478    Portugal 1,062    Kazakhstan 3,317    Morocco 2,642    Serbia 7,602    Jordan 1,116    Nepal 1,086    Cuba 7,628    Austria 2,283    Vietnam 10,489    Greece 2,322    Georgia 2,039    Guatemala 1,107    Belarus 1,967    Costa Rica 2,725    Bulgaria 1,724    Azerbaijan 1,783    Myanmar 2,187    Croatia 1,394    Ireland 1,413    Venezuela 1,064    Libya 1,053    Ethiopia 1,669    Lithuania 1,211    Mongolia 5,239    South Korea 2,008    Slovenia 1,325    Moldova 1,289    Botswana 6,608    Uganda 22,283    New Caledonia 1,112    China 96    Singapore 910    New Zealand 16    Australia 1,885   

WHO moves to update coronavirus guidance after great news in drug study

Christian Fernsby |
The World Health Organization (WHO) said it was moving to update its guidelines on treating people stricken with coronavirus to reflect results of a clinical trial that showed a cheap, common steroid can help save critically ill patients.

Article continues below



Topics: WHO   

Trial results announced on Tuesday showed dexamethasone, used since the 1960s to reduce inflammation in diseases such as arthritis, cut death rates by around a third among the most severely ill COVID-19 patients admitted to hospital.

The WHO’s clinical guidance for treating patients infected with the new coronavirus is aimed at doctors and other medical professionals and seeks to use the latest data to inform clinicians on how best to tackle all phases of the disease, from screening to discharge.

Although the dexamethasone study’s results are preliminary, the researchers behind the project said it suggests the drug should immediately become standard care in severely stricken patients.

For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO.

The benefit was only seen in patients seriously ill with COVID-19 and was not observed in patients with milder disease.

The positive news comes as coronavirus infections accelerated in some places including the United States and as Beijing cancelled scores of flights to help contain a fresh outbreak in China’s capital.

“This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support,” WHO Director-General Tedros Adhanom Ghebreyesus said in a statement late on Tuesday. The agency said it was looking forward to the full data analysis of the study in coming days.

“WHO will coordinate a meta-analysis to increase our overall understanding of this intervention. WHO clinical guidance will be updated to reflect how and when the drug should be used in COVID-19,” the agency added.


What to read next

There’s no medicine without side effect
Multi-drug implant shows promise for HIV prevention and treatment
Gut microbes eat our medication